Projects

Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

32 projects

  • Natural products as alternatives to antibiotics

    (Bio)pharmaPreventionOne healthSpecialized nutrition
    In this project natural herbal compounds will be evaluated for their antibacterial activity.

  • From virus to lung cell, from drug to patient

    (Bio)pharmaCurePharmacotherapyGlobal health
    This project aims to find new treatments for infection by Respiratory Syncytial Virus (RSV).

  • Construction of a Toolbox of enabling technology for coronavirus vaccine strategies

    (Bio)pharmaPreventionOne healthEnabling technologies
    Constructing a toolbox of enabling technology that can be used for the development of coronavirus vaccines.

  • In silico analysis of T-cell immunogenicity of seven pertussis proteins

    (Bio)pharmaPreventionGlobal healthOne health
    T-cell immunogenicity analysis of pertussis antigens aiding rational vaccine design of next-generation pertussis vaccines

  • Using nanotechnology to make better pharmaceuticals

    (Bio)pharmaCureCareEnabling technologies
    Developing novel manufacturing approaches for nano-engineered pharmaceutical materials.

  • Cell screening platform to test drugs for Alzheimers Disease

    (Bio)pharmaPreventionMolecular diagnosticsOne health
    A 3D neuronal stem cell screening platform for early drug discovery for Alzheimers Disease

  • Characterisation of Biomarkers for Non-Alcoholic Steatohepatitis

    (Bio)pharmaCureMolecular diagnosticsPharmacotherapy
    Characterization of clinical biomarkers in mice to bridge the gap between pre-clinical studies and patients